Titre : Arthrite réactionnelle

Arthrite réactionnelle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Arthrite réactionnelle : Questions médicales les plus fréquentes", "headline": "Arthrite réactionnelle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Arthrite réactionnelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-07", "dateModified": "2025-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Arthrite réactionnelle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles post-infectieux", "url": "https://questionsmedicales.fr/mesh/D000094025", "about": { "@type": "MedicalCondition", "name": "Troubles post-infectieux", "code": { "@type": "MedicalCode", "code": "D000094025", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.291.500.829" } } }, "about": { "@type": "MedicalCondition", "name": "Arthrite réactionnelle", "alternateName": "Arthritis, Reactive", "code": { "@type": "MedicalCode", "code": "D016918", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Henning Zeidler", "url": "https://questionsmedicales.fr/author/Henning%20Zeidler", "affiliation": { "@type": "Organization", "name": "Clinic of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany." } }, { "@type": "Person", "name": "Alan P Hudson", "url": "https://questionsmedicales.fr/author/Alan%20P%20Hudson", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine, Detroit, Michigan, USA." } }, { "@type": "Person", "name": "Prasanta Padhan", "url": "https://questionsmedicales.fr/author/Prasanta%20Padhan", "affiliation": { "@type": "Organization", "name": "Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, Odisha, India. prasanta.padhan@gmail.com." } }, { "@type": "Person", "name": "Sakir Ahmed", "url": "https://questionsmedicales.fr/author/Sakir%20Ahmed", "affiliation": { "@type": "Organization", "name": "Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, 751024, India. sakir005@gmail.com." } }, { "@type": "Person", "name": "Gian Luca Erre", "url": "https://questionsmedicales.fr/author/Gian%20Luca%20Erre", "affiliation": { "@type": "Organization", "name": "Specialità Mediche, Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.", "datePublished": "2023-09-13", "url": "https://questionsmedicales.fr/article/37620288", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/bju.16167" } }, { "@type": "ScholarlyArticle", "name": "Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer.", "datePublished": "2022-09-15", "url": "https://questionsmedicales.fr/article/36056577", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ijc.34274" } }, { "@type": "ScholarlyArticle", "name": "Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36063405", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/pros.24433" } }, { "@type": "ScholarlyArticle", "name": "Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.", "datePublished": "2024-06-03", "url": "https://questionsmedicales.fr/article/38833252", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.14582" } }, { "@type": "ScholarlyArticle", "name": "Prostate cancer risk prediction based on clinical factors and prostate-specific antigen.", "datePublished": "2023-06-03", "url": "https://questionsmedicales.fr/article/37270476", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12894-023-01259-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Caractéristiques de la maladie", "item": "https://questionsmedicales.fr/mesh/D020969" }, { "@type": "ListItem", "position": 5, "name": "Maladie chronique", "item": "https://questionsmedicales.fr/mesh/D002908" }, { "@type": "ListItem", "position": 6, "name": "Troubles post-infectieux", "item": "https://questionsmedicales.fr/mesh/D000094025" }, { "@type": "ListItem", "position": 7, "name": "Arthrite réactionnelle", "item": "https://questionsmedicales.fr/mesh/D016918" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Arthrite réactionnelle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Arthrite réactionnelle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Arthrite réactionnelle", "description": "Comment diagnostique-t-on l'arthrite réactionnelle ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes symptômes peuvent-ils aider au diagnostic ?\nL'arthrite réactionnelle est-elle toujours liée à une infection ?\nPeut-on utiliser des marqueurs inflammatoires pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D016918?mesh_terms=Prostatic+Neoplasms&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Arthrite réactionnelle", "description": "Quels sont les symptômes courants de l'arthrite réactionnelle ?\nL'arthrite réactionnelle provoque-t-elle de la fièvre ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?\nY a-t-il des symptômes extra-articulaires ?\nLes symptômes peuvent-ils disparaître sans traitement ?", "url": "https://questionsmedicales.fr/mesh/D016918?mesh_terms=Prostatic+Neoplasms&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Arthrite réactionnelle", "description": "Peut-on prévenir l'arthrite réactionnelle ?\nLes vaccinations aident-elles à prévenir l'arthrite réactionnelle ?\nY a-t-il des habitudes de vie à adopter ?\nLes traitements préventifs sont-ils disponibles ?\nL'éducation des patients peut-elle aider à la prévention ?", "url": "https://questionsmedicales.fr/mesh/D016918?mesh_terms=Prostatic+Neoplasms&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Arthrite réactionnelle", "description": "Quels traitements sont recommandés pour l'arthrite réactionnelle ?\nLes antibiotiques sont-ils efficaces pour traiter l'arthrite réactionnelle ?\nLa physiothérapie est-elle utile ?\nDes traitements biologiques sont-ils disponibles ?\nCombien de temps dure le traitement de l'arthrite réactionnelle ?", "url": "https://questionsmedicales.fr/mesh/D016918?mesh_terms=Prostatic+Neoplasms&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Arthrite réactionnelle", "description": "Quelles complications peuvent survenir avec l'arthrite réactionnelle ?\nL'arthrite réactionnelle peut-elle entraîner des problèmes cardiaques ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications de l'arthrite réactionnelle ?\nLes complications peuvent-elles affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D016918?mesh_terms=Prostatic+Neoplasms&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Arthrite réactionnelle", "description": "Quels sont les principaux facteurs de risque de l'arthrite réactionnelle ?\nL'âge influence-t-il le risque d'arthrite réactionnelle ?\nLes maladies auto-immunes augmentent-elles le risque ?\nLe mode de vie peut-il influencer le risque ?\nLes antécédents d'infections sexuellement transmissibles sont-ils un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D016918?mesh_terms=Prostatic+Neoplasms&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on l'arthrite réactionnelle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique, les antécédents d'infection et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang, des radiographies et parfois une arthrocentèse peuvent être effectuées." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils aider au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes comme la douleur articulaire et la conjonctivite sont indicatifs." } }, { "@type": "Question", "name": "L'arthrite réactionnelle est-elle toujours liée à une infection ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle se développe généralement après une infection, mais sans présence dans l'articulation." } }, { "@type": "Question", "name": "Peut-on utiliser des marqueurs inflammatoires pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des marqueurs comme la protéine C-réactive peuvent indiquer une inflammation." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de l'arthrite réactionnelle ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur articulaire, enflure, raideur et parfois conjonctivite." } }, { "@type": "Question", "name": "L'arthrite réactionnelle provoque-t-elle de la fièvre ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une légère fièvre peut accompagner l'inflammation articulaire." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement." } }, { "@type": "Question", "name": "Y a-t-il des symptômes extra-articulaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des lésions cutanées ou des problèmes oculaires peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils disparaître sans traitement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent voir leurs symptômes disparaître spontanément." } }, { "@type": "Question", "name": "Peut-on prévenir l'arthrite réactionnelle ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Prévenir les infections génito-urinaires et gastro-intestinales peut réduire le risque." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir l'arthrite réactionnelle ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations peuvent réduire le risque d'infections associées." } }, { "@type": "Question", "name": "Y a-t-il des habitudes de vie à adopter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et éviter les comportements à risque peuvent aider." } }, { "@type": "Question", "name": "Les traitements préventifs sont-ils disponibles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de traitements préventifs spécifiques pour l'arthrite réactionnelle." } }, { "@type": "Question", "name": "L'éducation des patients peut-elle aider à la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients sur les signes d'infection peut favoriser une détection précoce." } }, { "@type": "Question", "name": "Quels traitements sont recommandés pour l'arthrite réactionnelle ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les anti-inflammatoires non stéroïdiens (AINS) et les corticostéroïdes sont couramment utilisés." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces pour traiter l'arthrite réactionnelle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne traitent pas l'arthrite réactionnelle, car l'infection est résolue." } }, { "@type": "Question", "name": "La physiothérapie est-elle utile ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut aider à améliorer la mobilité et réduire la douleur." } }, { "@type": "Question", "name": "Des traitements biologiques sont-ils disponibles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements biologiques peuvent être envisagés dans les cas réfractaires aux AINS." } }, { "@type": "Question", "name": "Combien de temps dure le traitement de l'arthrite réactionnelle ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie, mais il peut durer plusieurs semaines à plusieurs mois." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'arthrite réactionnelle ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme l'arthrite chronique ou des problèmes oculaires peuvent survenir." } }, { "@type": "Question", "name": "L'arthrite réactionnelle peut-elle entraîner des problèmes cardiaques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines études suggèrent un lien entre arthrite réactionnelle et problèmes cardiaques." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications ne sont pas très fréquentes, mais elles peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "Comment gérer les complications de l'arthrite réactionnelle ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de l'arthrite réactionnelle ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les infections antérieures, le sexe masculin et des antécédents familiaux sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'arthrite réactionnelle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'arthrite réactionnelle est plus fréquente chez les jeunes adultes, généralement entre 20 et 40 ans." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des maladies auto-immunes peuvent avoir un risque accru." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise hygiène peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les antécédents d'infections sexuellement transmissibles sont-ils un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections sexuellement transmissibles peuvent augmenter le risque d'arthrite réactionnelle." } } ] } ] }

Sources (10000 au total)

Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.

To assess whether a diagnostic pathway in which prostate-specific membrane antigen (PSMA) positron-emission tomography (PET)/computed tomography (CT) is used as a single imaging modality is feasible t... A total of 60 men with a prostate-specific antigen (PSA) level of 20-50 ng/mL underwent... Lesions suspicious for PCa in the prostate gland were observed on all PSMA-PET/CTs. A total of 27/60 men (45%) already had metastatic disease on staging... Using the PSMA-driven single imaging modality pathway in biopsy-naïve men at high-risk of PCa, a substantial number of diagnostic MRI scans could be avoided while at the same time obtaining adequate t...

Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates.

The surgical treatment of men with lower urinary tract symptoms (LUTS) and significantly enlarged symptomatic prostates on active surveillance (AS) for low-risk prostate cancer (PCa) is not well defin... Men on AS who underwent HoLEP between 2013 and 2019 were identified. Data regarding preoperative cancer workup, prostate-specific antigen (PSA), perioperative outcomes, and voiding parameters were ana... Twenty men met the inclusion criteria. Preoperative mean max flow 7.9 ml/s, median postvoid residual 101 cc, and mean transrectal ultrasound prostate size 99 cc. Patients had a median adjusted preoper... Men on AS for low-risk PCa can safely undergo HoLEP with significantly improved voiding parameters. Postoperative monitoring with PSA, mpMRI, and PBx can detect disease progression requiring definitiv...

Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.

Prostate-specific antigen (PSA) screening for prostate cancer is controversial but may be associated with benefit for certain high-risk groups.... To evaluate associations of county-level PSA screening prevalence with prostate cancer outcomes, as well as variation by sociodemographic and clinical factors.... This cohort study used data from cancer registries based in 8 US states on Hispanic, non-Hispanic Black, and non-Hispanic White men aged 40 to 99 years who received a diagnosis of prostate cancer betw... County-level PSA screening prevalence was estimated using the Behavior Risk Factor Surveillance System survey data from 2004, 2006, 2008, 2010, and 2012 and weighted by population characteristics.... Multivariable logistic, Cox proportional hazards regression, and competing risks models were fit to estimate adjusted odds ratios (AOR) and adjusted hazard ratios (AHR) for associations of county-leve... Of 814 987 men with prostate cancer, the mean (SD) age was 67.3 (9.8) years, 7.8% were Hispanic, 12.2% were non-Hispanic Black, and 80.0% were non-Hispanic White; 17.0% had advanced disease. There wer... This population-based cohort study of men with prostate cancer suggests that higher county-level prevalence of PSA screening was associated with lower odds of advanced disease, all-cause mortality, an...

Prostate cancer risk prediction based on clinical factors and prostate-specific antigen.

The incidence rate of prostate cancer (PCa) has continued to rise in Korea. This study aimed to construct and evaluate a 5-year PCa risk prediction model using a cohort with PSA < 10 ng/mL by incorpor... The PCa risk prediction model including PSA levels and individual risk factors was constructed using a cohort of 69,319 participants from the Kangbuk Samsung Health Study. 201 registered PCa incidence... The risk prediction model included age, smoking status, alcohol consumption, family history of PCa, past medical history of dyslipidemia, cholesterol levels, and PSA level. Especially, an elevated PSA... Our risk prediction model was effective in predicting PCa in a population according to PSA levels. When PSA levels are inconclusive, an assessment of both PSA and specific individual risk factors (e.g...

Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.

Local recurrences after previous radiotherapy (RT) are increasingly being identified in biochemically recurrent prostate cancer. Salvage prostate brachytherapy (BT) is an effective and well tolerated ... International experts in salvage prostate BT were invited (n = 34) to participate. A three-round modified Delphi technique was utilized, with questions focused on patient- and cancer-specific criteria... Thirty international experts agreed to participate. Consensus was achieved for 56% (18/32) of statements. Consensus was achieved in several areas of patient selection: 1) A minimum of 2-3 years from i... Areas of consensus within our Delphi study may serve as practical advice for salvage prostate BT. Future research in salvage BT should address areas of controversy identified in our study....

Bidirectional influence between benign prostatic hyperplasia, prostate cancer, and prostatitis and mental disorders: two-sample and multivariate mendelian randomization analyses.

We aimed to use Mendelian randomization (MR) to determine the causality between fifteen major mental disorders (MDs) and benign prostatic hyperplasia (BPH), prostate cancer (PCa), and prostatitis.... The main MR analysis was performed using the inverse variance-weighted (IVW) method.... The study found that insomnia (odds ratio [OR], 1.6190;... Our findings provide clinicians with a basis for developing programs to prevent or treat MDs and prostatic diseases....

A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing.

To evaluate the feasibility of AI-assisted reading of prostate magnetic resonance imaging (MRI) in Organized Prostate cancer Testing (OPT).... Retrospective cohort study including 57 men with elevated prostate-specific antigen (PSA) levels ≥3 µg/L that performed bi-parametric MRI in OPT. The results of a CE-marked deep learning (DL) algorith... The number of positive MRIs was 13 (23%), 8 (14%), and 29 (51%) for the local radiologists, expert consensus, and DL, respectively. Kappa scores were moderate for local radiologists versus expert cons... The Dl-algorithm showed low agreement with both local and expert radiologists. Training and validation of DL-algorithms in specific screening cohorts is essential before introduction in organized test...